Solid Biosciences Inc. (SLDB) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 170 transactions totaling $114.0M, demonstrating a bullish sentiment with $90.1M in net insider flow. The most recent transaction on Feb 4, 2026 involved a sale of 7,205 shares valued at $46.4K.
No significant insider buying has been recorded for SLDB in the recent period.
No significant insider selling has been recorded for SLDB in the recent period.
Based on recent SEC filings, insider sentiment for SLDB is bullish with an Insider Alignment Score of 90/100 and a net flow of $90.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Solid Biosciences Inc. (SLDB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading SLDB stock, having executed 170 transactions in the past 90 days. The most active insider is Joseph Edelman (Executive), who has made 5 transactions totaling $45.2M.
Get notified when executives and directors at SLDB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Ganot Ilan | Executive | Sale | 7,205 | $6.44 | $46.4K | |
| Feb 4, 2026 | Cumbo Alexander | Executive | Sale | 48,913 | $6.44 | $315.1K | |
| Feb 4, 2026 | T. Howton David | Chief Operating Officer | Sale | 18,894 | $6.44 | $121.7K | C-Suite |
| Feb 4, 2026 | Herzich Paul | Chief Technology Officer | Sale | 10,905 | $6.44 | $70.2K | C-Suite |
| Jan 13, 2026 | Tan Kevin | CFO & Treasurer | Sale | 5,704 | $5.27 | $30.1K | C-Suite |
| Jan 9, 2026 | Tan Kevin | CFO & Treasurer | Option Exercise | 11,250 | $N/A | $0 | C-Suite |
| Jan 9, 2026 | Tan Kevin | CFO & Treasurer | Option Exercise | 11,250 | $N/A | $0 | C-Suite |
| Dec 3, 2025 | Herzich Paul | Executive | Sale | 2,701 | $5.11 | $13.8K | |
| Dec 3, 2025 | Hanrahan Jessie | Executive | Sale | 4,483 | $5.11 | $22.9K | |
| Dec 3, 2025 | Cumbo Alexander | Executive | Sale | 10,808 | $5.11 | $55.2K | |
| Dec 3, 2025 | T. Howton David | Executive | Sale | 4,932 | $5.11 | $25.2K | |
| Dec 2, 2025 | Herzich Paul | Executive | Option Exercise | 7,239 | $N/A | $0 | |
| Dec 2, 2025 | Hanrahan Jessie | Executive | Option Exercise | 11,862 | $N/A | $0 | |
| Dec 2, 2025 | Cumbo Alexander | Executive | Option Exercise | 28,612 | $N/A | $0 | |
| Dec 2, 2025 | T. Howton David | Executive | Option Exercise | 13,051 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 33 | $114.5M | 48.4% |
Purchase(P) | 10 | $102.0M | 43.1% |
Sale(S) | 73 | $11.9M | 5.0% |
Other(J) | 2 | $8.0M | 3.4% |
Payment(F) | 1 | $923 | 0.0% |
Exercise(M) | 49 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at Solid Biosciences Inc. are accumulating shares at an accelerated pace. With 32 insiders making 170 transactions totaling $102.0M in purchases versus $11.9M in sales, the net buying activity of $90.1M signals strong executive confidence. Joseph Edelman (Executive) leads the buying activity with $45.2M in transactions across all time.